» Articles » PMID: 31529626

Role of Porphyromonas Gingivalis in Oral Squamous Cell Carcinoma Development: A Systematic Review

Overview
Specialty Dentistry
Date 2019 Sep 19
PMID 31529626
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The target of the current systematic review is to gather and synthesize the most recent scientific information about the role of Porphyromonas gingivalis in the molecular pathways of oral squamous cell carcinoma (OSCC).

Background: Oral squamous cell carcinoma is the most common malignancy of the oral cavity, with a poor prognosis and a low survival rate. Etiology is multifactorial but consumption of tobacco and alcohol is the most important risk factors. P gingivalis is a Gram-negative anaerobic bacterium commonly found in oral microbiota that has been linked to periodontal disease (PD), and recently to OSCC. However, its association with OSCC development is not well defined.

Material And Methods: A bibliographic research was carried out selecting articles published until 2019, on PubMed, Web of Science, and Scopus databases, with the keywords "Porphyromonas gingivalis," "oral cancer," "oral squamous cell carcinoma," and "periodontal pathogen."

Results: Seventeen articles, 14 in vitro and three in animal models, were selected. Models mimicking OSCC were OSCC pre-established cell lines (11 studies), OSCC/ healthy human biopsies (three studies), and animals with OSCC (three studies). P gingivalis strains used to cause infection in these studies were ATCC 33277, 381, and W83.

Conclusions: Porphyromonas gingivalis could play an important role in OSCC development and could be involved in three different stages: epithelial-mesenchymal transition of malignant cells, neoplastic proliferation, and tumor invasion. Current findings emphasize the convenience of treatment and control approaches of PD as part of the primary prevention of OSCC.

Citing Articles

Correlation Between Periodontal Disease and Oral, Oropharyngeal, and Parapharyngeal Cancers.

Daily Z, Mohammed N, Mohammed S, Hussein H Clin Cosmet Investig Dent. 2025; 17:147-158.

PMID: 40027983 PMC: 11869753. DOI: 10.2147/CCIDE.S512557.


Systematic analyses uncover robust salivary microbial signatures and host-microbiome perturbations in oral squamous cell carcinoma.

Han Z, Hu Y, Lin X, Cheng H, Dong B, Liu X mSystems. 2025; 10(2):e0124724.

PMID: 39873508 PMC: 11834404. DOI: 10.1128/msystems.01247-24.


Peri-Implant Epstein-Barr Virus (+) Mucocutaneous Ulcer in an Immunocompetent Patient: Case Report and Review of the Literature.

Lafuente-Ibanez de Mendoza I, Aguirre-Echevarria P, Silva-Soria T, Aisa F, de Larrinoa A, Aguirre-Urizar J Clin Implant Dent Relat Res. 2025; 27(1):e13440.

PMID: 39823249 PMC: 11741149. DOI: 10.1111/cid.13440.


The Bidirectional Impact of Cancer Radiotherapy and Human Microbiome: Microbiome as Potential Anti-tumor Treatment Efficacy and Toxicity Modulator.

Palkovsky M, Modrackova N, Neuzil-Bunesova V, Liberko M, Soumarova R In Vivo. 2024; 39(1):37-54.

PMID: 39740900 PMC: 11705129. DOI: 10.21873/invivo.13803.


Oral Microbial Changes in Oral Squamous Cell Carcinoma: Focus on , , and .

Lee Y, Jung J, Hong J Medicina (Kaunas). 2024; 60(11).

PMID: 39596938 PMC: 11596053. DOI: 10.3390/medicina60111753.